Esbriet 267 MG tablet 270S
Ended Awarded
- Contract number
- SPE2DB25FY8RE
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,426
Award facts
- Contract value 100% obligated
- $3,425.95 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $3,425.95 delivery order to AmerisourceBergen Drug Corp for the supply of Esbriet 267 mg tablets (270 count) on July 31, 2025, with an ultimate completion date of August 21, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Esbriet (pirfenidone) is a pharmaceutical treatment for idiopathic pulmonary fibrosis, indicating this procurement supports DLA's medical supply chain for military and federal healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026. This prime contract vehicle enables comprehensive pharmaceutical and medical supply support across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems globally. AmerisourceBergen's federal contracting history demonstrates consistent capability in meeting competitive procurement requirements across diverse pharmaceutical products, with this specific delivery order representing routine fulfillment of critical medical commodities for federal military and healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FY8RE?
SPE2DB25FY8RE was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 31, 2025.
How much is contract SPE2DB25FY8RE worth?
The government has obligated $3,426 on SPE2DB25FY8RE.
Is contract SPE2DB25FY8RE an order under another contract?
Yes. SPE2DB25FY8RE is a delivery order under SPE2DB22D3301, an indefinite delivery contract.
Was contract SPE2DB25FY8RE competed?
The extent of competition for SPE2DB25FY8RE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award